JSM Activity #110

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2002 Program page


Activity ID:  110
Title
* Clinical Trial Design and Monitoring
Date / Time / Room Sponsor Type
08/12/2002
10:30 AM - 12:20 PM
Room: H-Concourse E 		Biometrics Section*, Biopharmaceutical Section*, ENAR, Section on Risk Analysis* Contributed
Organizer: n/a
Chair: Charles B. Hall, Albert Einstein College of Medicine
Discussant:  
Description

Good design is essential in clinical research. These papers will discuss current approaches to the design of early-phase trials, and of randomized trials where the units are not single patients but clusters of patients.
  301738  By:  Lurdes Y.T. Inoue 10:35 AM 08/12/2002
Adaptive Decision-making in a Lymphocyte Infusion Trial

  301516  By:  Siu L. Hui 10:50 AM 08/12/2002
Optimizing Pre-screening to Identify Potential Subjects for Early Intervention Trials

  301153  By:  Robert H. Lyles 11:05 AM 08/12/2002
Design and Analytic Considerations for Single-armed Studies Subject to Outcome Misclassification

  300524  By:  Ying-Kuen   Cheung 11:20 AM 08/12/2002
Monitoring the Rates of Composite Events with Censored Data in Phase II Clinical Trials

  301178  By:  Yi  Cheng 11:35 AM 08/12/2002
Asymptotic Optimal Sample Sizes for Discovering Promising Treatment in Phase II Group Sequential Clinical Trials.

  301865  By:  Gary L. Rosner 11:50 AM 08/12/2002
An Aid to Monitoring Phase II Studies in Cancer

  300569  By:  Rafael E. Diaz 12:05 PM 08/12/2002
Analysis of Cross Sectional Cluster Ranomized Designs With the Logistic-Normal Likelihood Ratio Test

JSM 2002

For information, contact meetings@amstat.org or phone (703) 684-1221.

If you have questions about the Continuing Education program, please contact the Education Department.

Revised March 2002